Table 3 PEDro Criteria and Scores of Included Studies
study | Random allocation | Concealed allocation | Baseline similar | Blinding (subject) | Blinding (therapists) | Blinding (Assessor) | Measure for>85% | Intention-to-Treat Analysis | Group Comparison | Point measures | Total score (0–10) |
|---|---|---|---|---|---|---|---|---|---|---|---|
Chen et al. (2018) | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Cebria I Iranzo et al. (2018) | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 7 |
Piastra et al. (2018) | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
Wei-Hua et al. (2020) | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Vikberg et al. (2019) | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
Bellomo et al. (2013) | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 5 |
Zhao et al. (2016) | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
Huang et al. (2017) | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Chen et al. (2017) | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
Liao et al. (2018) | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Liao et al. (2017) | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Hamaguchi et al. (2017) | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
Vasconcelos et al. (2016) | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Chiu et al. (2018) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 3 |